Longitudinal analysis of human plasma biomarkers for Alzheimer's disease: Phosphorylated Tau‐217, Phosphorylated Tau‐181, and Glial fibrillation acidic protein
The longitudinal analysis revealed intriguing trends that warrant further investigation with a larger sample size. Continued pursuit of pTau217 would be beneficial, given its strong correlation with amyloid status, which suggests potential as a valuable biomarker for AD disease progression.
Authors
- Gab Pasia (ORCID: https://orcid.org/0009-0005-9295-6855)
- Jefferson W. Kinney
- Aaron Ritter
- MayaRae N. Mugosa
- Mason Jonah
- Isabella Hou
Institutions
- Hoag Memorial Hospital Presbyterian (US)
- Cleveland Clinic (US)
- University of Nevada, Las Vegas (US)
- University of Nevada, Reno (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102320
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00